Volume 28, Number 2—February 2022
Research
Burden of Tick-Borne Encephalitis, Sweden
Daniel Slunge
, Anders Boman, and Marie Studahl
, Anders Boman, and Marie Studahl
Table 2
Burden of TBE in terms of healthcare use, sick leave days, and cost of illness per case, Sweden, 1998–2014*
| Variable |
Within 1 y after TBE onset |
Within 3 y after TBE onset |
Within 5 y after TBE onset |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare use and sick leave, no. |
Cost of illness/ case, € |
Share of total cost of illness, % |
Healthcare use and sick leave, no. |
Cost of illness/ case, € |
Share of total cost of illness, % |
Healthcare use and sick leave, no. |
Cost of illness/ case, € |
Share of total cost of illness, % |
|||
| Days hospitalized | 10.10 | 10,599 | 51.7 | 9.19 | 9,638 | 39.9 | 8.77 | 9,203 | 41.2 | ||
| Specialist outpatient visits | 1.80 | 610 | 3.0 | 2.63 | 890 | 3.7 | 3.09 | 1,045 | 4.8 | ||
| Primary care visits | 3.90 | 639 | 3.1 | 4.25 | 696 | 2.9 | 5.10 | 836 | 3.8 | ||
| Days of sick leave |
43.50 |
8,656 |
42.2 |
64.80 |
12,902 |
53.5 |
54.00 |
10,750 |
49.2 |
||
| Total | NA | 20,504 | NA | NA | 24,126 | NA | NA | 21,834 | NA | ||
*Calculations account for differences between TBE case-patients and referent cohort during a 3-y period before date of disease onset. NA, not applicable; TBE, tick-borne encephalitis.
Page created: December 02, 2021
Page updated: January 24, 2022
Page reviewed: January 24, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.